SCHEMBL29000383

SCHEMBL29000383

NC(=O)Oc1nc(Cc2ccc(C=O)cc2)cs1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ PARP10 Q53GL7 1/20 0.34
▸ PARP3 Q9Y6F1 1/20 0.34
▸ C1S P09871 1/20 0.31
▸ SCN9A Q15858 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28366435 0.75 GABRA5 (0.36) AOC3ALDH1A1KMT2AHPGD
SCHEMBL4753884 0.71 HTR2B (0.39) ALDH1A1MAPT
SCHEMBL23933151 0.71 AOC3 (0.50) AOC3ALDH1A1RAB9AMAPTSMN1; SMN2
SCHEMBL28803151 0.69 AOC3 (0.33) AOC3
SCHEMBL24622258 0.68 AOC3 (0.47) AOC3ALDH1A1RAB9AMAPTSMN1; SMN2
SCHEMBL23933145 0.68 KMT2A (0.35) ALDH1A1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL28366125 0.67 KDM4E (0.31) ALDH1A1
SCHEMBL10081937 0.65 KMT2A (0.58) ALDH1A1MAPTSMN1; SMN2KMT2APARP10
SCHEMBL15881332 0.65 POLB (0.43) ALDH1A1RAB9AMAPTSMN1; SMN2NPC1
SCHEMBL22322104 0.65 ALDH5A1 (0.45) ALDH1A1RAB9AMAPTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117015381-A Novel steroid payloads, steroid linkers, ADCs containing the same and uses thereof 伊穆奈克斯特股份有限公司 2023-11-07 — — CN disclosed
CN-116096413-A Anti-human VISTA antibodies and uses thereof 伊穆奈克斯特股份有限公司 2023-05-09 — — CN disclosed
Send feedback